Drag a card by its title · ⚙ to size, swap or remove

The company

Galectin Therapeutics Inc.

GALT · Nasdaq

Health CareBiotechnologyIn trend

GALT stood above a rising 150-day average in 16 of the last 52 weekly readings, including each of the last 8 weeks. It is 5.5% above that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).

SEC filings

Statistics

Rotation: In trend
Weeks in an uptrend: 8 in a row
Industry in uptrend: 18% -14 in 4 wk
Insider buys, 12 months: $65K
Insider sales, 12 months: $8.3M
Officials’ trades on record: 0
Institutions holding: 95 (+1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.

21 Apr – 20 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months6

Sale orders, 12 months44

Buyers · sellers2 · 6

Who	Did	Shares	Traded
Khurram JamilChief Medical Officer	sold	16,250at $5.13	14 Jul 2026filed 16 Jul 2026
Khurram JamilChief Medical Officer	sold	47,467at $5.04	29 Jun 2026filed 30 Jun 2026
Harold H. ShlevinDirector	sold	22,268at $5.04	29 Jun 2026filed 30 Jun 2026
Khurram JamilChief Medical Officer	sold	2,037at $5.00	26 Jun 2026filed 30 Jun 2026
Khurram JamilChief Medical Officer	sold	2,533at $5.00	26 Jun 2026filed 30 Jun 2026
Harold H. ShlevinDirector	sold	7,732at $5.00	26 Jun 2026filed 30 Jun 2026
Khurram JamilChief Medical Officer	sold	7,557at $3.14	23 Jun 2026filed 25 Jun 2026
Khurram JamilChief Medical Officer	sold	568at $3.10	26 May 2026filed 28 May 2026
Kary EldredDirector	bought	300at $2.70	6 Feb 2026filed 9 Feb 2026
Khurram JamilChief Medical Officer	sold	21,446at $3.65	6 Jan 2026filed 6 Jan 2026
Jack W. CallicuttChief Financial Officer	sold	20,354at $3.67	6 Jan 2026filed 6 Jan 2026
Joel LewisPresident and CEO	sold	37,698at $3.58	6 Jan 2026filed 6 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders95+1 on the quarter

New · exited20 · 19

Reported value$71.3M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BlackRock, Inc.added · filed 7 Aug 2026	2,988,353$13.9M	+2,189,116+273.9%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	2,168,065$10.1M	+201,523+10.2%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	1,308,394$6.1M	+695,608+113.5%
OSAIC HOLDINGS, INC.added · filed 14 Aug 2026	1,203,725$5.6M	+81,055+7.2%
MARSHALL WACE, LLPreduced · filed 13 Aug 2026	831,010$3.9M	-388,902−31.9%
Wealthspire Advisors, LLCunchanged · filed 11 Aug 2026	721,788$3.3M	00.0%
STATE STREET CORPadded · filed 7 Aug 2026	567,779$2.6M	+309,347+119.7%
COMMONWEALTH EQUITY SERVICES, LLCadded · filed 29 Jul 2026	407,113$1.9M	+40,000+10.9%
NORTHERN TRUST CORPadded · filed 13 Aug 2026	386,545$1.8M	+256,097+196.3%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026	366,476$1.7M	+62,235+20.5%